Tubular Breast Carcinoma
Back to Diseases List
Associated Genetic Biomarkers
NCI Definition: An invasive adenocarcinoma of the breast with a favorable prognosis. It is composed of tubular structures lined by a single layer of epithelium. 
There are 2 clinical trials for tubular breast carcinoma, of which 2 are open and 0 are completed or closed. Of the trials that contain tubular breast carcinoma as an inclusion criterion, 1 is phase 1 (1 open) and 1 is phase 3 (1 open).
ER, HER2, and PR are the most frequent gene inclusion criteria for tubular breast carcinoma clinical trials .
Radiation therapy and hypofractionated radiation therapy are the most common interventions in tubular breast carcinoma clinical trials.
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.
3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.